In August 2010 , the U.S. Food and Drug Administration issued draft guidelines for developing antibiotics for treating acute bacterial skin and skin structure infections ( ABSSSI ) , with the outcome measure of such treatment relying primarily on the cessation of spread or on the decrease in size of skin lesions at 48-72h after the initiation of such treatment .